293 related articles for article (PubMed ID: 12113916)
1. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.
Regenold WT; Thapar RK; Marano C; Gavirneni S; Kondapavuluru PV
J Affect Disord; 2002 Jun; 70(1):19-26. PubMed ID: 12113916
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and length of hospital stay among older adults with bipolar disorder, schizophrenia or schizoaffective disorder, depression, and dementia.
Sajatovic M; Friedman SH; Sabharwal J; Bingham CR
J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):3-8. PubMed ID: 15018690
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with overweight and obesity in schizophrenia, schizoaffective and bipolar disorders.
Chouinard VA; Pingali SM; Chouinard G; Henderson DC; Mallya SG; Cypess AM; Cohen BM; Öngür D
Psychiatry Res; 2016 Mar; 237():304-10. PubMed ID: 26805561
[TBL] [Abstract][Full Text] [Related]
4. Independence of diabetes and obesity in adults with serious mental illness: Findings from a large urban public hospital.
Sun L; Getz M; Daboul S; Jay M; Sherman S; Rogers E; Aujero N; Rosedale M; Goetz RR; Weissman J; Malaspina D; Ahmad S
J Psychiatr Res; 2018 Apr; 99():159-166. PubMed ID: 29482065
[TBL] [Abstract][Full Text] [Related]
5. Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients.
Regenold WT; Hisley KC; Obuchowski A; Lefkowitz DM; Marano C; Hauser P
J Affect Disord; 2005 Apr; 85(3):341-50. PubMed ID: 15780705
[TBL] [Abstract][Full Text] [Related]
6. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients.
Cassidy F; Ahearn E; Carroll BJ
Am J Psychiatry; 1999 Sep; 156(9):1417-20. PubMed ID: 10484954
[TBL] [Abstract][Full Text] [Related]
7. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.
Laursen TM; Agerbo E; Pedersen CB
J Clin Psychiatry; 2009 Oct; 70(10):1432-8. PubMed ID: 19538905
[TBL] [Abstract][Full Text] [Related]
8. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine therapy in treatment-resistant psychotic mood disorders: a long-term follow-up study.
Narendran R; Young CM; Valenti AM; Pristach CA; Pato MT; Grace JJ
J Clin Psychiatry; 2001 Jul; 62(7):509-16. PubMed ID: 11488360
[TBL] [Abstract][Full Text] [Related]
10. Common familial risk factors for schizophrenia and diabetes mellitus.
Foley DL; Mackinnon A; Morgan VA; Watts GF; Castle DJ; Waterreus A; Galletly CA
Aust N Z J Psychiatry; 2016 May; 50(5):488-94. PubMed ID: 26209325
[TBL] [Abstract][Full Text] [Related]
11. Association of Electroconvulsive Therapy With Psychiatric Readmissions in US Hospitals.
Slade EP; Jahn DR; Regenold WT; Case BG
JAMA Psychiatry; 2017 Aug; 74(8):798-804. PubMed ID: 28658489
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for metabolic syndrome in schizophrenia, schizoaffective, and bipolar disorder.
Mohd Ahmed H; Abdel Aziz K; Al Ammari A; Galadari M; Alsaadi A; Alhassani A; Al Marzooqi F; AlAhbabi M; Alsheryani H; Bahayan M; Ahmed R; Alameri S; Stip E; Aly El-Gabry D
Int J Psychiatry Clin Pract; 2024 Mar; 28(1):35-44. PubMed ID: 38329470
[TBL] [Abstract][Full Text] [Related]
13. Impaired glucose metabolism moderates the course of illness in bipolar disorder.
Mansur RB; Rizzo LB; Santos CM; Asevedo E; Cunha GR; Noto MN; Pedrini M; Zeni M; Cordeiro Q; McIntyre RS; Brietzke E
J Affect Disord; 2016 May; 195():57-62. PubMed ID: 26866976
[TBL] [Abstract][Full Text] [Related]
14. Polypharmacy in pregnant women with major psychiatric illness: a pilot study.
Peindl KS; Masand P; Mannelli P; Narasimhan M; Patkar A
J Psychiatr Pract; 2007 Nov; 13(6):385-92. PubMed ID: 18032983
[TBL] [Abstract][Full Text] [Related]
15. Exploring the borders of the schizoaffective spectrum: a categorical and dimensional approach.
Peralta V; Cuesta MJ
J Affect Disord; 2008 May; 108(1-2):71-86. PubMed ID: 18029027
[TBL] [Abstract][Full Text] [Related]
16. Clozapine in severe mood disorders.
Zarate CA; Tohen M; Baldessarini RJ
J Clin Psychiatry; 1995 Sep; 56(9):411-7. PubMed ID: 7665540
[TBL] [Abstract][Full Text] [Related]
17. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
van Winkel R; De Hert M; Wampers M; Van Eyck D; Hanssens L; Scheen A; Peuskens J
J Clin Psychiatry; 2008 Mar; 69(3):472-9. PubMed ID: 18348593
[TBL] [Abstract][Full Text] [Related]
18. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.
McElroy SL; Dessain EC; Pope HG; Cole JO; Keck PE; Frankenberg FR; Aizley HG; O'Brien S
J Clin Psychiatry; 1991 Oct; 52(10):411-4. PubMed ID: 1938976
[TBL] [Abstract][Full Text] [Related]
19. [Smoking in affective psychosis: review about nicotine use in bipolar and schizoaffective disorders].
López-Ortiz C; Roncero C; Miquel L; Casas M
Adicciones; 2011; 23(1):65-75. PubMed ID: 21503565
[TBL] [Abstract][Full Text] [Related]
20. Acutely ill psychiatric inpatients and antimicrobial exposure.
Kehoe KP; Miller BJ
Ann Clin Psychiatry; 2020 Nov; 32(4):229-238. PubMed ID: 33125447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
